179 related articles for article (PubMed ID: 29402176)
1. Estimating the frequency of indolent breast cancer in screening trials.
Shen Y; Dong W; Gulati R; Ryser MD; Etzioni R
Stat Methods Med Res; 2019 Apr; 28(4):1261-1271. PubMed ID: 29402176
[TBL] [Abstract][Full Text] [Related]
2. Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials.
Ryser MD; Gulati R; Eisenberg MC; Shen Y; Hwang ES; Etzioni RB
Am J Epidemiol; 2019 Jan; 188(1):197-205. PubMed ID: 30325415
[TBL] [Abstract][Full Text] [Related]
3. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
5. Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study.
Wu WY; Nyström L; Jonsson H
J Med Screen; 2018 Dec; 25(4):183-190. PubMed ID: 29153013
[TBL] [Abstract][Full Text] [Related]
6. Will supplemental screening ultrasound increase breast cancer overdiagnosis?
Molleran VM
Acad Radiol; 2015 Aug; 22(8):967-72. PubMed ID: 26100187
[TBL] [Abstract][Full Text] [Related]
7. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
Lee SJ; Li X; Huang H; Zelen M
Med Decis Making; 2018 Apr; 38(1_suppl):44S-53S. PubMed ID: 29554465
[TBL] [Abstract][Full Text] [Related]
8. [Overdiagnosis in mammography screening for breast cancer].
Huang YB; Yang L; Song FJ; Chen KX
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1574-1578. PubMed ID: 29141352
[TBL] [Abstract][Full Text] [Related]
9. Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.
Gulati R; Feuer EJ; Etzioni R
Am J Epidemiol; 2016 Jul; 184(2):140-7. PubMed ID: 27358266
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer biology varies by method of detection and may contribute to overdiagnosis.
Hayse B; Hooley RJ; Killelea BK; Horowitz NR; Chagpar AB; Lannin DR
Surgery; 2016 Aug; 160(2):454-62. PubMed ID: 27241117
[TBL] [Abstract][Full Text] [Related]
11. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
12. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer overdiagnosis in stop-screen trials: More uncertainty than previously reported.
Baker SG; Prorok PC
J Med Screen; 2021 Jun; 28(2):185-192. PubMed ID: 32838665
[TBL] [Abstract][Full Text] [Related]
14. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
15. Quality-of-life effects of screening mammography in Norway.
Zahl PH; Kalager M; Suhrke P; Nord E
Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
[TBL] [Abstract][Full Text] [Related]
16. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
Harding C; Pompei F; Burmistrov D; Wilson R
Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
18. Estimation of overdiagnosis by detection to incidence ratio in cancer screening.
Hakama M; Malila N
J Med Screen; 2019 Sep; 26(3):135-138. PubMed ID: 30987504
[No Abstract] [Full Text] [Related]
19. Overdiagnosis of breast cancer at screening is clinically insignificant.
Feig SA
Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
